HL7 Terminology (THO)
6.5.0 - Continuous Process Integration (ci build)
HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.5.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions
| Official URL: http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer | Version: 3.0.0 | |||
| Active as of 2014-03-26 | Responsible: Health Level Seven International | Computable Name: VaccineManufacturer | ||
| Other Identifiers: OID:2.16.840.1.113883.1.11.227 | ||||
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html |
||||
The manufacturer of a vaccine.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Language: en
http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer
Expansion performed internally based on codesystem VaccineManufacturer v3.0.0 (CodeSystem)
This value set contains 40 concepts
| Code | System | Display (en) | Definition |
| AB | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Abbott Laboratories (includes Ross Products Division) | Abbott Laboratories (includes Ross Products Division) |
| AD | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Adams Laboratories | Adams Laboratories |
| ALP | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation |
| AR | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Armour [Inactive - use CEN] | Armour \[Inactive-use CEN\] |
| AVI | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Aviron | Aviron |
| BA | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Baxter Healthcare Corporation | Baxter Healthcare Corporation |
| BAY | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) |
| BP | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Berna Products [Inactive - use BPC] | Berna Products \[Inactive-use BPC\] |
| BPC | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) |
| CEN | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Centeon L.L.C. (includes Armour Pharmaceutical Company) | Centeon L.L.C. (includes Armour Pharmaceutical Company) |
| CHI | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Chiron Corporation | Chiron Corporation |
| CON | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Connaught [Inactive - use PMC] | Connaught \[Inactive-use PMC\] |
| EVN | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) |
| GRE | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Greer Laboratories, Inc. | Greer Laboratories, Inc. |
| IAG | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Immuno International AG | Immuno International AG |
| IM | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Merieux [Inactive - use PMC] | Merieux \[Inactive-use PMC\] |
| IUS | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Immuno-U.S., Inc. | Immuno-U.S., Inc. |
| JPN | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) |
| KGC | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Korea Green Cross Corporation | Korea Green Cross Corporation |
| LED | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Lederle [Inactive - use WAL] | Lederle \[Inactive-use WAL\] |
| MA | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories |
| MED | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | MedImmune, Inc. | MedImmune, Inc. |
| MIL | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Miles [Inactive - use BAY] | Miles \[Inactive-use BAY\] |
| MIP | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Bioport Corporation (formerly Michigan Biologic Products Institute) | Bioport Corporation (formerly Michigan Biologic Products Institute) |
| MSD | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Merck and Co., Inc. | Merck & Co., Inc. |
| NAB | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | NABI (formerly North American Biologicals, Inc.) | NABI (formerly North American Biologicals, Inc.) |
| NAV | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | North American Vaccine, Inc. | North American Vaccine, Inc. |
| NOV | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) |
| NYB | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | New York Blood Center | New York Blood Center |
| ORT | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Ortho Diagnostic Systems, Inc. | Ortho Diagnostic Systems, Inc. |
| OTC | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Organon Teknika Corporation | Organon Teknika Corporation |
| PD | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Parkedale Pharmaceuticals (formerly Parke-Davis) | Parkedale Pharmaceuticals (formerly Parke-Davis) |
| PMC | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) |
| PRX | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Praxis Biologics [Inactive - use WAL] | Praxis Biologics \[Inactive-use WAL\] |
| SCL | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Sclavo, Inc. | Sclavo, Inc. |
| SI | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Swiss Serum and Vaccine Inst. [Inactive - use BPC] | Swiss Serum and Vaccine Inst. \[Inactive-use BPC\] |
| SKB | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | SmithKline Beecham | SmithKline Beecham |
| USA | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | United States Army Medical Research and Materiel Command | United States Army Medical Research and Materiel Command |
| WA | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Wyeth-Ayerst [Inactive - use WAL] | Wyeth-Ayerst \[Inactive-use WAL\] |
| WAL | http://terminology.hl7.org/CodeSystem/v3-VaccineManufacturer | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
History
| Date | Action | Author | Custodian | Comment |
| 2023-11-14 | revise | Marc Duteau | TSMG | Add standard copyright and contact to internal content; up-476 |
| 2022-10-18 | revise | Marc Duteau | TSMG | Fixing missing metadata; up-349 |
| 2020-05-06 | revise | Ted Klein | Vocabulary WG | Migrated to the UTG maintenance environment and publishing tooling. |
| 2014-03-26 | revise | Vocabulary (Woody Beeler) (no record of original request) | 2014T1_2014-03-26_001283 (RIM release ID) | Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 |